Immunovant, Inc. SEC filings IMVT

Immunovant, Inc. has 648 filings in SEC EDGAR's recent list, going back to Jan 23, 2019. Its latest annual report, Form ARS, was filed on Jul 22, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 3, 2026 (shareholder vote results). The company's fiscal year ends on March 31.

Immunovant, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 30, 2026 Oct 28, 2026
4 Insider transaction Oct 23, 2026 Oct 21, 2026
4 Insider transaction Oct 9, 2026 Oct 7, 2026
4 Insider transaction Oct 9, 2026 Oct 7, 2026
4 Insider transaction Oct 9, 2026 Oct 7, 2026
4 Insider transaction Oct 5, 2026 Oct 1, 2026
4 Insider transaction Sep 25, 2026 Sep 23, 2026
8-K Current report
Shareholder vote results
Sep 3, 2026 Sep 2, 2026
4 Insider transaction Aug 28, 2026 Aug 28, 2026
4 Insider transaction Aug 21, 2026 Aug 20, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jul 24, 2026 Jul 24, 2026
4 Insider transaction Jul 24, 2026 Jul 23, 2026
4 Insider transaction Jul 24, 2026 Jul 23, 2026
ARS Annual report to shareholders Jul 22, 2026 Mar 31, 2026
DEFA14A Additional proxy material Jul 22, 2026 —
DEF 14A Proxy statement Jul 22, 2026 Sep 2, 2026
4 Insider transaction Jul 10, 2026 Jul 8, 2026
4 Insider transaction Jul 10, 2026 Jul 8, 2026
4 Insider transaction Jul 10, 2026 Jul 8, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
4 Insider transaction May 29, 2026 May 28, 2026
144 Notice of proposed sale May 28, 2026 —
4 Insider transaction May 22, 2026 May 20, 2026
4 Insider transaction May 20, 2026 May 20, 2026
144 Notice of proposed sale May 20, 2026 —
10-K Annual report May 20, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 20, 2026 May 20, 2026
4 Insider transaction May 1, 2026 May 1, 2026
144 Notice of proposed sale May 1, 2026 —
4 Insider transaction Apr 24, 2026 Apr 23, 2026
4 Insider transaction Apr 24, 2026 Apr 23, 2026
4 Insider transaction Apr 10, 2026 Apr 8, 2026
4 Insider transaction Apr 10, 2026 Apr 8, 2026
4 Insider transaction Apr 10, 2026 Apr 8, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 9, 2026 Apr 7, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Feb 27, 2026 Feb 25, 2026
144 Notice of proposed sale Feb 10, 2026 —
10-Q Quarterly report Feb 6, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 6, 2026 Feb 6, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Dec 19, 2025 Dec 18, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 12, 2025 —
4 Insider transaction Dec 12, 2025 Dec 12, 2025
8-K Current report
Other events
Dec 12, 2025 Dec 10, 2025
424B5 Prospectus supplement Dec 12, 2025 —
8-K Current report
Other events
Dec 11, 2025 Dec 10, 2025
FWP Free writing prospectus Dec 11, 2025 —
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
144 Notice of proposed sale Dec 1, 2025 —
144 Notice of proposed sale Dec 1, 2025 —
144 Notice of proposed sale Nov 26, 2025 —
144 Notice of proposed sale Nov 25, 2025 —
4 Insider transaction Nov 21, 2025 Nov 20, 2025
8-K Current report
Officer or director change
Nov 21, 2025 Nov 21, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2025 —
4 Insider transaction Oct 24, 2025 Oct 22, 2025
4 Insider transaction Oct 24, 2025 Oct 22, 2025
4 Insider transaction Oct 10, 2025 Oct 8, 2025
4 Insider transaction Oct 10, 2025 Oct 8, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 3, 2025 Sep 3, 2025
8-K Current report
Shareholder vote results
Aug 28, 2025 Aug 27, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
8-K Current report
Officer or director change
Jul 29, 2025 Jul 28, 2025
4 Insider transaction Jul 25, 2025 Jul 23, 2025
4 Insider transaction Jul 25, 2025 Jul 23, 2025
4 Insider transaction Jul 11, 2025 Jul 9, 2025
4 Insider transaction Jul 11, 2025 Jul 9, 2025
ARS Annual report to shareholders Jul 9, 2025 Mar 31, 2025
DEFA14A Additional proxy material Jul 9, 2025 —
DEF 14A Proxy statement Jul 9, 2025 Aug 27, 2025
144 Notice of proposed sale Jun 25, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale Jun 3, 2025 —
10-K Annual report May 29, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 29, 2025 May 29, 2025
144 Notice of proposed sale May 21, 2025 —
144 Notice of proposed sale May 19, 2025 —
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
S-8 Employee stock plan registration Apr 30, 2025 —
3 Initial insider ownership Apr 28, 2025 Apr 21, 2025
3 Initial insider ownership Apr 28, 2025 Apr 18, 2025
3 Initial insider ownership Apr 28, 2025 Apr 18, 2025
4 Insider transaction Apr 25, 2025 Apr 23, 2025
4 Insider transaction Apr 25, 2025 Apr 23, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 21, 2025 —
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Apr 21, 2025 Apr 18, 2025
4 Insider transaction Apr 17, 2025 Apr 16, 2025
4 Insider transaction Apr 17, 2025 Apr 16, 2025
4 Insider transaction Apr 11, 2025 Apr 9, 2025
4 Insider transaction Apr 11, 2025 Apr 9, 2025
4 Insider transaction Apr 11, 2025 Apr 9, 2025
4 Insider transaction Apr 11, 2025 Apr 9, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
SCHEDULE 13G Ownership over 5% (passive) Mar 26, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Mar 19, 2025 Mar 19, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
144 Notice of proposed sale Mar 7, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 7, 2025 —
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
144 Notice of proposed sale Feb 14, 2025 —
144 Notice of proposed sale Feb 11, 2025 —
10-Q Quarterly report Feb 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 6, 2025 Feb 6, 2025
8-K Current report
Other events
Jan 24, 2025 Jan 24, 2025
424B3 Prospectus Jan 24, 2025 —
4 Insider transaction Jan 24, 2025 Jan 22, 2025
4 Insider transaction Jan 24, 2025 Jan 22, 2025
D Filing Jan 21, 2025 —
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 15, 2025 Jan 13, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 15, 2025 —
8-K Current report
Regulation FD disclosure
Jan 14, 2025 Jan 14, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Jan 10, 2025 Jan 8, 2025
4 Insider transaction Jan 10, 2025 Jan 8, 2025
4 Insider transaction Dec 18, 2024 Dec 16, 2024
3 Initial insider ownership Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
144 Notice of proposed sale Dec 2, 2024 —
144 Notice of proposed sale Dec 2, 2024 —
4 Insider transaction Nov 22, 2024 Nov 20, 2024
4 Insider transaction Nov 22, 2024 Nov 20, 2024
4 Insider transaction Nov 22, 2024 Nov 20, 2024
4 Insider transaction Nov 22, 2024 Nov 20, 2024
4 Insider transaction Nov 20, 2024 Nov 18, 2024
3 Initial insider ownership Nov 20, 2024 Nov 18, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations, Other events
Nov 7, 2024 Nov 7, 2024
4 Insider transaction Oct 25, 2024 Oct 23, 2024
4 Insider transaction Oct 25, 2024 Oct 23, 2024
4 Insider transaction Oct 25, 2024 Oct 23, 2024
4 Insider transaction Oct 18, 2024 Oct 16, 2024
4 Insider transaction Oct 18, 2024 Oct 16, 2024
4 Insider transaction Oct 18, 2024 Oct 16, 2024
4 Insider transaction Oct 18, 2024 Oct 16, 2024
4 Insider transaction Oct 11, 2024 Oct 9, 2024
4 Insider transaction Oct 11, 2024 Oct 9, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 9, 2024 Sep 9, 2024
4 Insider transaction Aug 23, 2024 Aug 21, 2024
4 Insider transaction Aug 23, 2024 Aug 21, 2024
4 Insider transaction Aug 23, 2024 Aug 21, 2024
4 Insider transaction Aug 23, 2024 Aug 21, 2024
4 Insider transaction Aug 23, 2024 Aug 21, 2024
8-K Current report
Shareholder vote results
Aug 13, 2024 Aug 12, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
4 Insider transaction Jul 26, 2024 Jul 24, 2024
4 Insider transaction Jul 26, 2024 Jul 24, 2024
4 Insider transaction Jul 26, 2024 Jul 24, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
IMVT (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Durham, NC
SEC filer status
Large accelerated filer
SEC CIK
1764013
Former names
Health Sciences Acquisitions Corp (until Dec 20, 2019)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.